FRESENIUS MEDICAL CARE | 69.22 / +1.44% |
Date/Time | 01/22 / 17:24 |
Chg. / Chg.(%) | 0.98 / +1.44% |
Bid | 67.28 / 2000 |
Ask | 71.14 / 2000 |
Open | 69.22 |
Previous Close | 68.24 |
High | 69.22 |
Low | 69.22 |
Volume [EUR] | 3,807.10 |
Volume [Units] | 55 |
Price fixings | 1 |
ISIN | DE0005785802 |
Security | FME |
Exchange | Borsa Italiana |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
Lang & Schwa.. | 69.140 | ![]() |
|
Xetra | 69.22 | ![]() |
588,608 |
Cboe Europe .. | 69.22 | ![]() |
246,162 |
Turquoise | 69.16 | ![]() |
139,354 |
London Inter.. | 69.28 | ![]() |
138,805 |
TradeGate | 69.560 | ![]() |
11,442 |
Stuttgart | 69.300 | ![]() |
3,469 |
gettex | 69.300 | ![]() |
2,032 |
Frankfurt | 69.3200 | ![]() |
516 |
München | 68.64 | ![]() |
425 |
Cboe Europe .. | 68.91 | ![]() |
156 |
Düsseldorf | 69.18 | ![]() |
100 |
Hamburg | 68.84 | ![]() |
57 |
Borsa Italia.. | 69.22 | ![]() |
55 |
Hannover | 69.36 | ![]() |
51 |
Berlin | 69.28 | ![]() |
33 |
Cboe Europe .. | 69.36 | ![]() |
23 |
Vienna Globa.. | 69.18 | ![]() |
0 |
Nasdaq Other.. | 82.6200 | 1,000 | |
Mexico | 1,938.55 | ![]() |
760 |
EUREX | Options |
News
- ChemoCentryx and VFMCRP Provide Topline Results from ACCOLADE Trial of Avacopan in C3 Glomerulopathy Including Improved Estimated Glomerular Filtration Rate (eGFR)
12/21/2020 / 22:05 - GlobeNewswire - Vifor Pharma and Angion Sign License Agreement for ANG-3777 in Nephrology Indications
11/09/2020 / 07:00 - GlobeNewswire - ChemoCentryx and VFMCRP announce European Medicines Agency has accepted to review the Marketing Authorization Application for avacopan
11/03/2020 / 14:30 - GlobeNewswire - Vifor Pharma and Cara Therapeutics sign US license agreement for IV Korsuva™* to treat dialysis patients with pruritus
10/20/2020 / 07:00 - GlobeNewswire - ChemoCentryx and VFMCRP Announce Topline Data from Phase II LUMINA-1 Trial of CCX140 in Focal Segmental Glomerulosclerosis (FSGS)
05/18/2020 / 14:30 - GlobeNewswire